Anti-Extravasation Catheter
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 8,357,126 | Anti-Extravasation Catheter In force · High confidence | Cannuflow, Inc. | In force | High confidence | ||
| US 8,647,322 | Anti-Extravasation Catheter Lapsed Feb 11, 2026 on the fee record Ended Feb 11, 2026 · High confidence | Cannuflow, Inc. | Lapsed Feb 11, 2026 on the fee record | Ended Feb 11, 2026 | High confidence | |
| US 10,456,510 | Anti-Extravasation Catheter Term ended Term ended Oct 24, 2026 · High confidence | Cannuflow, Inc. | Term ended | Term ended Oct 24, 2026 | High confidence | |
| Application 16/666,120 | Anti-Extravasation Catheter Abandoned Abandoned Mar 7, 2022 | Cannuflow, Inc. | Abandoned | Abandoned Mar 7, 2022 |
4 of 4 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
1 of these is in force and held by Cannuflow, Inc..
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.